$BPTH
BIO-PATH HOLDINGS, INC.

2018 Q3 Form 10-Q Financial Statement

#000114420418044625 Filed on August 14, 2018

View on sec.gov

Income Statement

Concept 2018 Q3 2018 Q2 2017 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $740.0K $850.0K $850.0K
YoY Change -16.85% 0.0% 11.84%
% of Gross Profit
Research & Development $2.342M $827.0K $1.480M
YoY Change 47.95% -44.12% 24.37%
% of Gross Profit
Depreciation & Amortization $110.0K $100.0K $120.0K
YoY Change -8.33% -16.67% 140.0%
% of Gross Profit
Operating Expenses $3.082M $1.679M $2.325M
YoY Change 24.47% -27.78% 19.6%
Operating Profit -$3.082M -$1.679M -$2.325M
YoY Change 24.47% -27.78%
Interest Expense $0.00 $0.00 $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $1.000K $2.000K $340.0K
YoY Change -50.0% -99.41% 16900.0%
Pretax Income -$3.080M -$1.680M -$1.990M
YoY Change 24.7% -15.58% 2.58%
Income Tax
% Of Pretax Income
Net Earnings -$3.081M -$1.677M -$1.985M
YoY Change 24.54% -15.52% 2.21%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$5.404M -$2.947M -$4.061M
COMMON SHARES
Basic Shares Outstanding 11.34M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q3 2018 Q2 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.290M $2.580M $6.180M
YoY Change -50.43% -58.25% 46.45%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $281.0K $604.0K $1.600M
YoY Change -75.78% -62.25% -13.98%
Inventory
Prepaid Expenses $257.0K $1.332M
Receivables
Other Receivables
Total Short-Term Assets $2.824M $4.514M $7.790M
YoY Change -51.23% -42.05% 28.13%
LONG-TERM ASSETS
Property, Plant & Equipment $473.0K $539.0K $800.0K
YoY Change -34.31% -32.63% 1468.63%
Goodwill
YoY Change
Intangibles $648.0K $689.0K
YoY Change -19.9%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.121M $1.228M $1.640M
YoY Change -26.73% -25.12% 54.72%
TOTAL ASSETS
Total Short-Term Assets $2.824M $4.514M $7.790M
Total Long-Term Assets $1.121M $1.228M $1.640M
Total Assets $3.945M $5.742M $9.430M
YoY Change -46.11% -39.11% 32.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $451.0K $137.0K $100.0K
YoY Change 275.83% 37.0% -16.67%
Accrued Expenses $506.0K $868.0K $470.0K
YoY Change -19.68% 84.68% -31.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $957.0K $1.005M $580.0K
YoY Change 24.77% 73.28% -28.66%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $957.0K $1.005M $580.0K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $957.0K $1.005M $580.0K
YoY Change 24.77% 73.28% -28.66%
SHAREHOLDERS EQUITY
Retained Earnings -$45.83M -$42.75M
YoY Change 23.9%
Common Stock $13.00K $11.00K
YoY Change -87.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.988M $4.737M $8.860M
YoY Change
Total Liabilities & Shareholders Equity $3.945M $5.742M $9.430M
YoY Change -46.08% -39.11% 32.07%

Cashflow Statement

Concept 2018 Q3 2018 Q2 2017 Q2
OPERATING ACTIVITIES
Net Income -$3.081M -$1.677M -$1.985M
YoY Change 24.54% -15.52% 2.21%
Depreciation, Depletion And Amortization $110.0K $100.0K $120.0K
YoY Change -8.33% -16.67% 140.0%
Cash From Operating Activities -$1.470M -$1.710M -$2.360M
YoY Change -3.92% -27.54% 4.89%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$120.0K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$120.0K
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.180M 0.000 1.550M
YoY Change -4033.33% -100.0%
NET CHANGE
Cash From Operating Activities -1.470M -1.710M -2.360M
Cash From Investing Activities 0.000 0.000 -120.0K
Cash From Financing Activities 1.180M 0.000 1.550M
Net Change In Cash -290.0K -1.710M -930.0K
YoY Change -81.41% 83.87% -58.67%
FREE CASH FLOW
Cash From Operating Activities -$1.470M -$1.710M -$2.360M
Capital Expenditures $0.00 $0.00 -$120.0K
Free Cash Flow -$1.470M -$1.710M -$2.240M
YoY Change -3.92% -23.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
642000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
390000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.99 pure
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0269 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0206 pure
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q2 us-gaap Cash
Cash
2578000 USD
CY2017Q4 us-gaap Cash
Cash
5965000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2018Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
100000 USD
CY2017Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
100000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
us-gaap Net Income Loss
NetIncomeLoss
-3593000 USD
us-gaap Net Income Loss
NetIncomeLoss
-2382000 USD
CY2017Q4 us-gaap Other Inventory
OtherInventory
1100000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
39000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1332000 USD
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1117000 USD
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q2 us-gaap Other Assets Current
OtherAssetsCurrent
604000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
353000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
989000 shares
us-gaap Payments To Suppliers
PaymentsToSuppliers
200000 USD
dei Document Period End Date
DocumentPeriodEndDate
2018-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
us-gaap Adjustment For Amortization
AdjustmentForAmortization
80000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
80000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
546000 shares
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
827000 USD
CY2017Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1480000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1759000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2506000 USD
CY2018Q2 us-gaap Assets Current
AssetsCurrent
4514000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7435000 USD
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2017Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-778000 USD
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11341000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11339000 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1839000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1815000 USD
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
852000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
845000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.60
us-gaap Depreciation
Depreciation
132000 USD
us-gaap Depreciation
Depreciation
108000 USD
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
BIO-PATH HOLDINGS INC
us-gaap Share Based Compensation
ShareBasedCompensation
263000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
507000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.73
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
1679000 USD
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
2325000 USD
us-gaap Operating Expenses
OperatingExpenses
3598000 USD
us-gaap Operating Expenses
OperatingExpenses
4321000 USD
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11341000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11339000 shares
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1001000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
984000 USD
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
462000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
330000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3598000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4321000 USD
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1679000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2325000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
11.88
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2374000 USD
dei Entity Central Index Key
EntityCentralIndexKey
0001133818
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-440000 USD
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
10.61
CY2018Q2 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
200000 USD
CY2017Q4 bpth Accrued Vacation And Bonus
AccruedVacationAndBonus
100000 USD
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
539000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
654000 USD
CY2017Q4 bpth Accrued Clinical And Preclinical
AccruedClinicalAndPreclinical
400000 USD
CY2018Q2 bpth Accrued Clinical And Preclinical
AccruedClinicalAndPreclinical
500000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2374000 USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
215000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
216000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
251000 USD
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
109000 USD
dei Trading Symbol
TradingSymbol
BPTH
CY2018Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2017Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-440000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-440000 USD
CY2018Q2 bpth Accrued License Maintenance Fee
AccruedLicenseMaintenanceFee
100000 USD
CY2017Q4 bpth Accrued License Maintenance Fee
AccruedLicenseMaintenanceFee
100000 USD
CY2018Q2 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500000 USD
CY2017Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
2500000 USD
CY2018Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1811000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1731000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2018Q2 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
5000 USD
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2000 USD
CY2018Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11340756 shares
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
214000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-257000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-1677000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-1985000 USD
CY2018Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
689000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
769000 USD
CY2018Q2 us-gaap Assets
Assets
5742000 USD
CY2017Q4 us-gaap Assets
Assets
8858000 USD
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3370000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4203000 USD
CY2018Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
CY2017Q2 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-1038000 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
0 USD
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
-1038000 USD
CY2018Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
25000000 USD
CY2018Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1000000 USD
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1677000 USD
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3023000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3593000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3420000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
538000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-538000 USD
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
100000 USD
CY2017Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
300000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
500000 USD
CY2018Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
137000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
52000 USD
CY2018Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
868000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
739000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M18D
CY2018Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
800000 USD
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1005000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
791000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-3387000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-3193000 USD
CY2016Q4 us-gaap Cash
Cash
9375000 USD
CY2018Q2 us-gaap Liabilities
Liabilities
1005000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
791000 USD
CY2017Q2 us-gaap Cash
Cash
6182000 USD
CY2016Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
588235 shares
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2016Q2 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
9300000 USD
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47476000 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47213000 USD
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-42750000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39157000 USD
bpth Warrants Transferred To Equity Upon Modification
WarrantsTransferredToEquityUponModification
0 USD
bpth Warrants Transferred To Equity Upon Modification
WarrantsTransferredToEquityUponModification
797000 USD
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
4737000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8067000 USD
CY2017Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1500000 USD
CY2016Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
25000 shares
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5742000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8858000 USD
CY2017Q2 bpth Class Of Warrant Or Right Exercisable Number
ClassOfWarrantOrRightExercisableNumber
441176 shares
CY2017Q2 bpth Class Of Warrant Or Right Exercised Number
ClassOfWarrantOrRightExercisedNumber
11176 shares
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
400000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-200000 USD
us-gaap Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings
AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings
1000000 USD
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 USD
CY2017Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
340000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1939000 USD
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2017Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11341000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9712000 shares
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11341000 shares
CY2017Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9859000 shares
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1548000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1548000 USD
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.76
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.98
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
0 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
175000 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
0 USD
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
30000 USD

Files In Submission

Name View Source Status
0001144204-18-044625-index-headers.html Edgar Link pending
0001144204-18-044625-index.html Edgar Link pending
0001144204-18-044625.txt Edgar Link pending
0001144204-18-044625-xbrl.zip Edgar Link pending
bpth-20180630.xml Edgar Link completed
bpth-20180630.xsd Edgar Link pending
bpth-20180630_cal.xml Edgar Link unprocessable
bpth-20180630_def.xml Edgar Link unprocessable
bpth-20180630_lab.xml Edgar Link unprocessable
bpth-20180630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv499945_10q.htm Edgar Link pending
tv499945_ex31.htm Edgar Link pending
tv499945_ex32.htm Edgar Link pending